bedaquiline tablets

Bedaquiline is a diarylquinoline antimycobacterial drug, commonly used in tablet form. This product is used as part of combination therapy for the treatment of multidrug-resistant tuberculosis (MDR-TB) in adults (≥18 years old).

This product should only be used when no other effective treatment options are available. This product should be treated under direct supervision (DOT).

Based on two Phase II clinical trials, the indications of this product were determined by analyzing the time for sputum culture conversion to negative in patients with multidrug-resistant tuberculosis (MDR-TB).